30 March 2016 – WHO is rigorously reviewing reports of P. falciparum genetic mutations in some African settings to determine their accuracy and supporting countries to investigate suspected false negative rapid diagnostic test (RDT) results consistent with a missing pfhrp2 gene.
5 March 2016 – Dr Pedro Alonso has been awarded the Ronald Ross Medal by the London School of Hygiene and Tropical Medicine. The medal is awarded every 3 years in recognition of outstanding contributions to the advancement of tropical public health or tropical medicine
29 February 2016 – The technical brief covers several key strategic areas aimed at controlling and eliminating P. vivax including diagnostic testing and treatment, G6PD deficiency and radical cure with primaquine, and surveillance.
24 February 2016 – The report on the Septmber 2015 Malaria Policy Advisory Committee meeting is now available. The report and all related documentation can be consulted on the dedicated MPAC meetings page.
23 February 2016 – This module is designed to provide the necessary skills and knowledge to assess the feasibility of malaria elimination in a given area and to prepare a national or sub-national plan for an elimination programme.
12 February 2016 – The next meeting of the Malaria Policy Advocacy Committee (MPAC) will take place in Geneva, Switzerland on 16–17 March. All related documentation can be found on the MPAC meetings page.
3 February 2016 – This manual is designed to assist managers of national malaria programmes and reference laboratories in investing in quality assurance of malaria microscopy. It will be released in French and Spanish soon.
29 January 2016 – RTS,S/AS01 is a vaccine that provides partial protection against P. falciparum, the most deadly malaria parasite globally. The recently updated Q&A on malaria vaccines provides additional information.
15 January 2016 – These recommendations focus on the use of LLINs treated with a pyrethroid insecticide and piperonyl butoxide, and on the need to gather more evidence on conditions and settings where they have increased efficacy compared to pyrethroid-only LLINs.
9 January 2016 – WHO, FIND and US CDC have released the latest report on malaria RDT product testing. The report provides a comparative measure of RDT performance in a standardized way to distinguish between well and poorly performing tests.